A Breakthrough in R&D for Neglected Diseases: New Ways to Get the Drugs We Need
Author:
Open Access
- 8 September 2005
- journal article
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 2 (9) , e302
Abstract
New research suggests that long-held beliefs on neglected disease drug development activity are no longer accurate.Keywords
This publication has 4 references indexed in Scilit:
- Focus: SchistosomiasisNature Reviews Microbiology, 2004
- New estimates of drug development costsJournal of Health Economics, 2003
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Access to Essential Drugs in Poor CountriesJAMA, 1999